DIADEMA PARTNERS LP Q4 2025 Filing
Filed February 17, 2026
Portfolio Value
$580.5B
Holdings
119
Report Date
Q4 2025
Filing Type
13F-HR
All Holdings (119 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | PRQRPROQR THRAPEUTICS N V | 167,532 | $338.0M | 0.06% | |
| 102 | HRMYHARMONY BIOSCIENCES HLDGS IN | 7,500 | $280.0M | 0.05% | |
| 103 | AARDAARDVARK THERAPEUTICS INC | 15,882 | $208.0M | 0.04% | |
| 104 | PBYIPUMA BIOTECHNOLOGY INC | 33,800 | $201.0M | 0.03% | Call |
| 105 | NEUPNEUPHORIA THERAPEUTICS INC | 50,000 | $194.0M | 0.03% | |
| 106 | PLRXPLIANT THERAPEUTICS INC | 144,914 | $176.0M | 0.03% | |
| 107 | ONCBEONE MEDICINES LTD | 7,500 | $172.0M | 0.03% | |
| 108 | FHTXFOGHORN THERAPEUTICS INC | 30,630 | $165.0M | 0.03% | |
| 109 | TLPHTALPHERA INC | 136,923 | $156.0M | 0.03% | |
| 110 | —REVIVA PHARMACEUTCLS HLDGS I | 500,000 | $139.0M | 0.02% | Call |
| 111 | VTGNVISTAGEN THERAPEUTICS INC | 206,500 | $136.0M | 0.02% | Call |
| 112 | PRTCPURETECH HEALTH PLC | 7,442 | $123.0M | 0.02% | |
| 113 | LYELLYELL IMMUNOPHARMA INC | 3,800 | $116.0M | 0.02% | Put |
| 114 | INBXINHIBRX BIOSCIENCES INC | 1,299 | $102.0M | 0.02% | |
| 115 | EDSAEDESA BIOTECH INC | 54,025 | $76.0M | 0.01% | |
| 116 | ATYRATYR PHARMA INC | 27,300 | $21.0M | 0.00% | Put |
| 117 | SAVACASSAVA SCIENCES INC | 10,600 | $20.0M | 0.00% | Put |
| 118 | JBIOJADE BIOSCIENCES INC | 1,046 | $2.0M | 0.00% | Put |
| 119 | APLTAPPLIED THERAPEUTICS INC | 20,200 | $2.0M | 0.00% | Call |
PreviousPage 2 of 2